Death of Covaxin volunteer due to cardiorespiratory failure and not related to vaccine trial, placebo: Bharat Biotech MD Bureau10 Jan 2021 11:00 AM IST"As per the post mortem report issued by the Gandhi Medical College, Bhopal, that the site received from the Bhopal Police, the probable cause of...
High Dose of Oral thiamine Effective for Treating Chronic Fatigue of IBD MD Bureau8 Jan 2021 5:00 PM ISTFatigue is a burdensome symptom for patients with inflammatory bowel disease (IBD) even with IBD in remission. In a recent study, researchers of the...
Cadila Healthcare gets CDSCO panel go-ahead for Phase 3 trial of Novel Corona Virus 2019-nCoV Vaccine MD Bureau7 Jan 2021 5:28 PM ISTNew Delhi: Pharmaceutical major, Cadila Healthcare has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Wockhardt secures CDSCO panel conditional nod to conduct Phase IV Trial of Levonadifloxacin MD Bureau6 Jan 2021 6:18 PM ISTNew Delhi: Pharmaceutical and biotechnology major Wockhardt Ltd. has recently secured permission from the Subject Expert Committee (SEC) of the...
Sun Pharma begins Phase 2 Trial of SCD-044 for Plaque Psoriasis Ruchika Sharma5 Jan 2021 12:41 PM ISTMumbai: Sun Pharmaceutical Industries Limited today announced that the company has initiated Phase 2 clinical trial for SCD-044 (a novel, orally...
Covaxin: Bharat Biotech recruits 13000 volunteers for Phase 3 trials Ruchika Sharma23 Dec 2020 1:10 PM ISTThe indigenously developed COVID-19 vaccine has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National...
New drug tirzepatide tied to superior blood sugar and weight control in diabetes: SURPASS-1 trial Medha Baranwal19 Dec 2020 11:30 AM ISTUSA: Tirzepatide led to superior produced strikingly positive effects in type 2 diabetes (T2D) patients, reveal results from phase 3,...
Zydus Cadila gets DCGI nod for Phase 1 trial of novel molecule ZYIL1 Ruchika Sharma7 Dec 2020 2:22 PM ISTNew Delhi: Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical...
Clinical trial participants paid over Rs 12 crore compensation in last 3 years for adverse events: DCGI Ruchika Sharma6 Dec 2020 11:00 AM ISTAddressing a webinar, ''Regulatory Pathways for COVID19 Vaccines, Clinical trials, Rolling Reviews and Adverse Event Monitoring'', Drugs Controller...
COVID-19: Zydus Cadila gets DCGI nod to start phase 3 trials with Pegylated Interferon alpha-2b in India Ruchika Sharma5 Dec 2020 12:17 PM ISTPegylated Interferon alpha-2b,'PegiHep' is an approved drug and is being re-purposed for the treatment of COVID-19.
Hybrid closed-loop systems cost-effective option for blood sugar control in T1D MD Bureau3 Dec 2020 12:45 PM ISTHybrid closed-loop therapy is likely to be cost-effective compared with multiple daily injections and capillary glucose for Type 1 diabetes patients...
Dr Reddys, RDIF begin Sputnik V clinical trials in India Ruchika Sharma2 Dec 2020 12:47 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. and Russian Direct Investment Fund (RDIF) have recently announced that they have commenced adaptive phase...
